Patients and healthcare professionals should report any suspected adverse reactions to medicines including those received as part of a clinical trial via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
More research is needed to fully understand NADs long-term benefits and safety
AI can enable the design of novel drugs binding to the GLP-1 receptor and predicting their binding ability with the receptor
For most patients, sustained cardiometabolic benefit will require long-term, continuous use, making one-time or short-term coverage insufficient
Global, regional, and national burdens of ischemic heart disease and stroke attributable to exposure to long working hours for 194 countries, 2000-2016: a systematic analysis from the Who/Ilo joint estimates of the work-related burden of disease and injury
Alcohol can impair hepatic gluconeogenesis and may mask the symptoms of hypoglycemia, making detection and treatment more challenging